Wuffy and Other ‘AI’ Dogs
Can these “robot” puppies replace man’s best friend?
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Pending
Can these “robot” puppies replace man’s best friend?
Can you actually work out without the work?
MADISON, CONN. Feb. 11, 2026 – A company calling itself “Patent & Trademark Office” is violating the FTC’s Impersonation Rule as well as the FTC Act by falsely posing as…
Complaint to FTC cites violations of agency’s Impersonation Rule.
TINA.org digs into shop’s purported Newport roots, and more.